(Q41549146)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Switching between cyclosporin formulations. What are the risks? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A J Olyaei

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W M Bennett

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

366-373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9241491%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-199716060-00003

4 November 2019

exact match

0 references

cites work

An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing

1 reference

12 December 2020

Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters

1 reference

12 December 2020

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

12 December 2020

Cyclosporine: mechanisms of action and toxicity.

1 reference

12 December 2020

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group

1 reference

12 December 2020

Neoral in liver transplantation.

1 reference

12 December 2020

Cyclosporine-induced hypertension after transplantation

1 reference

12 December 2020

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

1 reference

12 December 2020

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

12 December 2020

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

1 reference

12 December 2020

Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.

1 reference

12 December 2020

Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function

1 reference

12 December 2020

Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine

1 reference

12 December 2020

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

1 reference

12 December 2020

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

12 December 2020

Pharmacodynamic monitoring of cyclosporin

1 reference

12 December 2020

Safety and tolerability of Neoral in transplant recipients

1 reference

12 December 2020

Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion

1 reference

12 December 2020

Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation.

1 reference

12 December 2020

Hypertension following kidney transplantation

1 reference

12 December 2020

Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy

1 reference

12 December 2020

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

1 reference

12 December 2020

Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.

1 reference

12 December 2020

Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients.

1 reference

12 December 2020

1 reference

12 December 2020

Which cyclosporin formulation?

1 reference

12 December 2020

Cyclosporin clinical pharmacokinetics

1 reference

12 December 2020

Using cyclosporine Neoral immediately after liver transplantation. United Kingdom Neoral Pilot Study Group

1 reference

12 December 2020

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

12 December 2020

Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients

1 reference

12 December 2020

Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy

1 reference

12 December 2020

Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril

1 reference

12 December 2020

Long-term results of conversion from existing to microemulsion formulation of cyclosporine.

1 reference

12 December 2020

Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years

1 reference

12 December 2020

Prevention and management of the adverse effects associated with immunosuppressive therapy

1 reference

12 December 2020

Pharmacology of immunosuppressive medications used in renal diseases and transplantation

1 reference

12 December 2020

Abbreviated area-under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period

1 reference

12 December 2020

Which cyclosporin formulation?

1 reference

12 December 2020

Clinical development of cyclosporine

1 reference

12 December 2020

Small-bowel length and the dose of cyclosporine in children after liver transplantation

1 reference

12 December 2020

Which cyclosporin formulation?

1 reference

12 December 2020